Evidence of altered neuropeptide Y content and neuropeptide Y1 receptor gene expression in the hypothalamus of pregnant transgenic mice

Endocrinology. 2003 Nov;144(11):4826-30. doi: 10.1210/en.2003-0197. Epub 2003 Aug 13.

Abstract

Alterations in the density of neuropeptide Y (NPY)-immunoreactive fibers and of NPY1 receptor gene expression in the hypothalamus of Y1R/LacZ transgenic pregnant mice were investigated. In the paraventricular nucleus of mice on the 18th d of pregnancy NPY immunoreactivity was significantly decreased, and NPY1 receptor gene expression, as measured by histochemical staining of beta-galactosidase and in situ hybridization of NPY1 receptor mRNA, was significantly increased compared with those in estrous mice. Conversely, pregnant transgenic mice displayed a significant induction of NPY immunoreactivity and a reduction of NPY1 receptor gene expression in the ventromedial nucleus. A significant increase in Y1R/LacZ transgene expression and NPY1 receptor mRNA, but no changes in NPY immunoreactivity were observed in the arcuate nucleus of mice on the 18th d of pregnancy. These results suggest that the elevated expression of NPY in the ventromedial nucleus may contribute to the state of leptin resistance that occurs during pregnancy.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Arcuate Nucleus of Hypothalamus / metabolism
  • Female
  • Gene Expression*
  • Hypothalamus / metabolism*
  • Mice
  • Mice, Transgenic
  • Neuropeptide Y / metabolism*
  • Paraventricular Hypothalamic Nucleus / metabolism
  • Pregnancy
  • Pregnancy, Animal / metabolism*
  • Receptors, Neuropeptide Y / genetics*
  • Tissue Distribution
  • Ventromedial Hypothalamic Nucleus / metabolism
  • beta-Galactosidase / metabolism

Substances

  • Neuropeptide Y
  • Receptors, Neuropeptide Y
  • neuropeptide Y-Y1 receptor
  • beta-Galactosidase

Grants and funding